Results 141 to 150 of about 216,830 (202)

In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis. [PDF]

Biomedicines
Joelsson JP, Parnham MJ, Froment L, Rapet A, Hugi A, Stucki J, Hobi N, Kricker JA.   +7 more
europepmc   +1 more source

A Study of the Correlation Between the Inflammatory Index and Disease Activity in Ulcerative Colitis. [PDF]

Int J Gen Med
Chenfei Z, Ainiwaer Z, Xiaoling H.
europepmc   +1 more source

Upadacitinib after tofacitinib in ulcerative colitis. [PDF]

Intest Res
Cho HJ, Kim ES.
europepmc   +1 more source

Prognostic Prediction Models for Ulcerative Colitis: Systematic Review and Meta-Analysis.

J Med Internet Res
Bu Z, Sun Y, Shi Z, Hu L, Ju C, Liu Y, An J, Sun H, Liu J, Liu Z.   +9 more
europepmc   +1 more source

Serum Oncostatin M in Ulcerative Colitis Patients and Its Relation to Disease Activity. [PDF]

Int J Mol Sci
Jucan AE, Sarbu GE, Mihai VC, Atodiresei C, Juncu S, Mihai IR, Pavel-Tanasa M, Constantinescu D, Dranga M, Nedelciuc O, Iosep DG, Danciu M, Diaconescu S, Gîlca-Blanariu GE, Andronic AM, Toader E, Drug VL, Prelipcean CC, Mihai C.   +18 more
europepmc   +1 more source

Biomarkers of mitochondrial permeability transition-driven necrosis in the regulation of ulcerative colitis. [PDF]

PeerJ
Sun M, Ni F, Yao Y, Yang H.
europepmc   +1 more source

Prevalence of Cytomegalovirus in Patients With Newly Diagnosed, Flare-Up, and Acute Severe Ulcerative Colitis. [PDF]

Cureus
Shrestha M, Shrestha R, Khanal A, Basnet B, Poudyal NS, Yadav AK, Paudel MS.   +6 more
europepmc   +1 more source